The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2012 by GIAMPAOLO VELO, Universita di Verona.
Recruitment status was: Not yet recruiting
First Posted: November 27, 2012
Last Update Posted: November 29, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Ospedale S.Bortolo -Vicenza, Italy
Ospedale Mater Salutis-Legnago(Verona), Italy
Ospedale Fra Castoro- San Bonifacio (Verona), Italy
Azienda Ospedaliera Universitaria Integrata Verona
Information provided by (Responsible Party):
GIAMPAOLO VELO, Universita di Verona
A medication error is a failure in the treatment process that leads to, or has the potential to lead, to harm to the patient.1 Medication errors are a common unfortunate occurrence in hospital. They can occur in different phases of the therapeutic process (prescribing, distribution, administration and monitoring) and have significant impact on morbidity and mortality. Prescribing faults and prescription errors are major problem among medication errors .Prescription errors account for 70 % of medication errors that could potentially result in adverse drug effects.2 Overall it has been estimated prescription errors affect 7 % of medication orders, 2% of patient days and 50 % of hospital admissions.3,4 When harm arises from a medication error it is potentially preventable. The medication errors project was devised to analyze and limit through educational audit and other tools, as much as possible, damages due to the therapeutic process. The project will include 5 phases. Preliminary phase: organizational meetings. Phase I: Patient monitoring: a monitor in collaboration with health professionals of involved units will review all patient charts and will register all adverse drug reactions(ADRs). All ADRs will be introduced by the monitor in a database. Health professional will be invited to send the reports of observed ADRs. Evaluation of ADRs : a panel of experts will evaluate if the ADRs are due to medication errors or not. Phase II :educational audits directed to health professionals will be organized. Tools to reduce the medication errors will be proposed. Phase III: the same procedure of the first phase. Final phase (IV): analysis of data with publication of a scientific article.
||Observational Model: Cohort
Time Perspective: Prospective
||A Regional Project to Reduce Adverse Drug Reactions Due to Medication Errors in Hospital
Primary Outcome Measures:
- Number of participants with adverse drug reactions due to medication errors occurring during hospitalization [ Time Frame: within the first 3 months ]
Secondary Outcome Measures:
- Number of participants with preventable ADRs due to medication errors [ Time Frame: 3 months ]
Other Outcome Measures:
- the impact of educational audit will be evaluated [ Time Frame: during the final phase ]
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||November 2013 (Final data collection date for primary outcome measure)
ALL THE PATIENTS HOSPITALIZED IN THE INVOLVED UNITS WHO GAVE THEIR INFORMED CONSENT. PATIENTS HOSPITALIZED DURING THE WEEK-END WILL BE ENROLLED ON the next MONDAY